Inadequate control of heart rate in patients with stable angina: Results from the European Heart Survey

Postgraduate Medical Journal

Volumn 86, Issue 1014, 2010, Pages 212-217

  Daly, Caroline A ^a   Clemens, Felicity ^b   Lopez Sendon, Jose L ^c   Tavazzi, Luigi ^d   Boersma, Eric ^e   Danchin, Nicolas ^f   Delahaye, François ^g   Gitt, Anselm ^h   Julian, Desmond ⁱ   Mulcahy, David ^j   Ruzyllo, Witold ^k   Thygesen, Kristian ^l   Verheugt, Freek ^m   Fox, Kim M ^a  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^d FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^e ERASMUS MEDICAL CENTER   (Netherlands)

^f HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^g LOUIS PRADEL HOSPITAL   (France)

^h Herzzentrum Luwigshafen   (Germany)

ⁱ NEWCASTLE UNIVERSITY   (United Kingdom)

^j ADELAIDE AND MEATH HOSPITAL   (Ireland)

^k INSTITUTE OF CARDIOLOGY   (Poland)

^l AARHUS UNIVERSITY HOSPITAL   (Denmark)

^m RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL; BISOPROLOL; CALCIUM CHANNEL BLOCKING AGENT; CARVEDILOL; DILTIAZEM; ISOSORBIDE DINITRATE; METOPROLOL; NICORANDIL; VERAPAMIL; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ADULT; ARTICLE; CARDIOLOGIST; CHRONIC RESPIRATORY TRACT DISEASE; CLINICAL ASSESSMENT; COHORT ANALYSIS; COMORBIDITY; DIABETES MELLITUS; DISEASE ASSOCIATION; HEALTH SURVEY; HEART FAILURE; HEART RATE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; STABLE ANGINA PECTORIS; ANGINA PECTORIS; ARRHYTHMIAS, CARDIAC; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPLICATION; FEMALE; HYPERTENSION; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; RISK FACTOR; VASCULAR DISEASE;

ADRENERGIC BETA-ANTAGONISTS; ANGINA PECTORIS; ANTI-ARRHYTHMIA AGENTS; ARRHYTHMIAS, CARDIAC; DIABETES COMPLICATIONS; FEMALE; HEART RATE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; VASCULAR DISEASES;

EID: 77950857191     PISSN: 00325473     EISSN: 14690756     Source Type: Journal    
DOI: 10.1136/pgmj.2009.084384     Document Type: Article

References (26)

1. Fox K, Borer JS, Camm AJ, et al. Resting heart rate in cardiovascular disease. J Am Coll Cardiol 2007;50:823-30. (Pubitemid 47277500)
2. Colin P, Ghaleh B, Monnet X, et al. Effect of graded heart rate reduction with ivabradine on myocardial oxygen consumption and diastolic time in exercising dogs. J Pharmacol Exp Ther 2004;308:236-40. (Pubitemid 38090723)
3. Colin P, Ghaleh B, Monnet X, et al. Contributions of heart rate and contractility to myocardial oxygen balance during exercise. Am J Physiol Heart Circ Physiol 2003; 284:H676-82. (Pubitemid 36142896)
4. Collins P, Fox KM. Pathophysiology of angina. Lancet 1990;335:94-6. (Pubitemid 20018708)
5. Andrews TC, Fenton T, Toyosaki N, et al. Subsets of ambulatory myocardial ischemia based on heart rate activity. Circadian distribution and response to anti-ischemic medication. The Angina and Silent Ischemia Study Group (ASIS). Circulation 1993;88:92-100. (Pubitemid 23195437)
6. Kop WJ, Verdino RJ, Gottdiener JS, et al. Changes in heart rate and heart rate variability before ambulatory ischemic events(1). J Am Coll Cardiol 2001;38:742-9. (Pubitemid 32835746)
7. Krittayaphong R, Biles PL, Christy CG, et al. Association between angina pectoris and ischemic indexes during exercise testing and ambulatory monitoring. Am J Cardiol 1996;78:266-70. (Pubitemid 26265265)
8. Dyer AR, Persky V, Stamler J, et al. Heart rate as a prognostic factor for coronary heart disease and mortality: findings in three Chicago epidemiologic studies. Am J Epidemiol 1980;112:736-49. (Pubitemid 11130662)
9. Gillum RF. The epidemiology of resting heart rate in a national sample of men and women: associations with hypertension, coronary heart disease, blood pressure, and other cardiovascular risk factors. Am Heart J 1988;116(1 Pt 1):163-74.
10. Gillum RF, Makuc DM, Feldman JJ. Pulse rate, coronary heart disease, and death: the NHANES I Epidemiologic Follow-up Study. Am Heart J 1991; 121(1 Pt 1):172-7.
11. Diaz A, Bourassa MG, Guertin MC, et al. Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease. Eur Heart J 2005;26:967-74. (Pubitemid 40695027)
12. Fox K, Ford I, Steg PG, et al. Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial. Lancet 2008;372:817-21.
13. Ferrari R. Prognostic benefits of heart rate reduction in cardiovascular diseases. Eur Heart J 2003;5(Suppl G):G10-14. (Pubitemid 37236875)
14. Kjekshus JK. Importance of heart rate in determining beta-blocker efficacy in acute and long-term acute myocardial infarction intervention trials. Am J Cardiol 1986;57:43F-49F.
15. Cucherat M. Quantitative relationship between resting heart rate reduction and magnitude of clinical benefits in post-myocardial infarction: a meta-regression of randomized clinical trials. Eur Heart J 2007;28:3012-19. (Pubitemid 350262265)
16. Fox K, Ford I, Steg PG, et al. Relationship between ivabradine treatment and cardiovascular outcomes in patients with stable coronary artery disease and left ventricular systolic dysfunction with limiting angina: a subgroup analysis of the randomized, controlled BEAUTIFUL trial. Eur Heart J 2009;30:2337-45.
17. Graham I, Atar D, Borch-Johnsen K, et al. European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and Other Societys on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nice societys and by invited experts). Eur Heart J 2007;28:2375-414. http://www.escardio.org/NR/rdonlyres/70DDD632-75F3-4902-8B23- EC08243163F8/0/guidelines-CVD-ES-2007.pdf (accessed 18 Sep 2007). (Pubitemid 47470068)
18. Daly CA, Clemens F, Sendon JL, et al. The clinical characteristics and investigations planned in patients with stable angina presenting to cardiologists in Europe: from the Euro Heart Survey of Stable Angina. Eur Heart J 2005;26:996-1010. (Pubitemid 40695031)
19. Daly CA, De Stavola B, Sendon JL, et al. Predicting prognosis in stable anginaeresults from the Euro heart survey of stable angina: prospective observational study. BMJ 2006;332:262-7. (Pubitemid 43235332)
20. Daly CA, Clemens F, Sendon JL, et al. The initial management of stable angina in Europe, from the Euro Heart Survey: a description of pharmacological management and revascularization strategies initiated within the first month of presentation to a cardiologist in the Euro Heart Survey of Stable Angina. Eur Heart J 2005;26:1011-22. (Pubitemid 40695032)
21. Fox K, Garcia MA, Ardissino D, et al. Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology. Eur Heart J 2006;27:1341-81. (Pubitemid 43998110)
22. Gibbons RJ, Abrams J, Chatterjee K, et al. ACC/AHA 2002 guidelines update for the management of patients with chronic stable angina. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for the Management of Patients with Chronic Stable Angina). J Am Coll Cardiol 2003;41:159-68. http://www.americanheart.org/downloadable/hear/1044991838085StableAnginaNewFigs. pdf (accessed 15 Jun 2007).
23. Dargie HJ, Ford I, Fox KM. Total Ischaemic Burden European Trial (TIBET). Effects of ischaemia and treatment with atenolol, nifedipine SR and their combination on outcome in patients with chronic stable angina. The TIBET Study Group. Eur Heart J 1996;17:104-12.
24. Rehnqvist N, Hjemdahl P, Billing E, et al. Effects of metoprolol vs verapamil in patients with stable angina pectoris. The Angina Prognosis Study in Stockholm (APSIS). Eur Heart J 1996;17:76-81. (Pubitemid 26239260)
25. Gottlieb SS, McCarter RJ, Vogel RA. Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction. N Engl J Med 1998;339:489-97. (Pubitemid 28384881)
26. Salpeter S, Ormiston T, Salpeter E. Cardioselective beta-blockers for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2005;(4):CD003566.